Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schuster

Showing results (211-220 of 219) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 219 results.
Plos Genetics|January 14, 2014
C/EBPα is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitorsMarie S Hasemann, Felicia K B Lauridsen, Johannes Waage, et al.
Cancer Cell|April 9, 2008
Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cellsPeggy Kirstetter, Mikkel B Schuster, Oksana Bereshchenko, et al.
Toxicology Letters|February 22, 2023
Issues in the inhalation toxicity testing and hazard assessment for low density particulate materials such as synthetic amorphous silica (SAS)Wolfgang Dekant, Evangelia E Antoniou, Axel Bosch, et al.
Toxicology Letters|September 2, 2023
Corrigendum to "Issues in the inhalation toxicity testing and hazard assessment for low density particulate materials such as synthetic amorphous silica (SAS)" [Toxicol. Lett. (in press)]Wolfgang Dekant, Evangelia E Antoniou, Axel Bosch, et al.
Nature Communications|October 4, 2023
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expressionElizabeth Heyes, Anna S Wilhelmson, Anne Wenzel, et al.
Science Advances|July 17, 2019
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AMLJanus S Jakobsen, Linea G Laursen, Mikkel B Schuster, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 7, 2021
Atopic dermatitis: disease characteristics and comorbidities in smoking and non-smoking patients from the TREATgermany registryA C Pilz, M C Schielein, B Schuster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2015
Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patientsM Hecht, L Zimmer, C Loquai, et al.
FEMS Microbiology Reviews|June 1, 1997
Applications of S-layersU B Sleytr, H Bayley, M Sára, et al.
Pageof 22

Showing results (211-220 of 219) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 219 results.
Plos Genetics|January 14, 2014
C/EBPα is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitorsMarie S Hasemann, Felicia K B Lauridsen, Johannes Waage, et al.
Cancer Cell|April 9, 2008
Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cellsPeggy Kirstetter, Mikkel B Schuster, Oksana Bereshchenko, et al.
Toxicology Letters|February 22, 2023
Issues in the inhalation toxicity testing and hazard assessment for low density particulate materials such as synthetic amorphous silica (SAS)Wolfgang Dekant, Evangelia E Antoniou, Axel Bosch, et al.
Toxicology Letters|September 2, 2023
Corrigendum to "Issues in the inhalation toxicity testing and hazard assessment for low density particulate materials such as synthetic amorphous silica (SAS)" [Toxicol. Lett. (in press)]Wolfgang Dekant, Evangelia E Antoniou, Axel Bosch, et al.
Nature Communications|October 4, 2023
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expressionElizabeth Heyes, Anna S Wilhelmson, Anne Wenzel, et al.
Science Advances|July 17, 2019
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AMLJanus S Jakobsen, Linea G Laursen, Mikkel B Schuster, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 7, 2021
Atopic dermatitis: disease characteristics and comorbidities in smoking and non-smoking patients from the TREATgermany registryA C Pilz, M C Schielein, B Schuster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2015
Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patientsM Hecht, L Zimmer, C Loquai, et al.
FEMS Microbiology Reviews|June 1, 1997
Applications of S-layersU B Sleytr, H Bayley, M Sára, et al.
Pageof 22